Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometriosis | 10 | 2023 | 834 | 3.510 |
Why?
|
| CA-125 Antigen | 5 | 2021 | 279 | 2.610 |
Why?
|
| Ovarian Neoplasms | 17 | 2023 | 4823 | 2.360 |
Why?
|
| Dysmenorrhea | 3 | 2023 | 86 | 1.150 |
Why?
|
| Dyspareunia | 1 | 2022 | 50 | 0.850 |
Why?
|
| Postmenopause | 2 | 2021 | 2461 | 0.780 |
Why?
|
| Mexican Americans | 1 | 2021 | 166 | 0.720 |
Why?
|
| Early Detection of Cancer | 3 | 2023 | 3070 | 0.680 |
Why?
|
| Pelvic Pain | 4 | 2023 | 273 | 0.670 |
Why?
|
| Nutrition Assessment | 1 | 2021 | 723 | 0.610 |
Why?
|
| Mucin-1 | 1 | 2021 | 543 | 0.550 |
Why?
|
| Premenopause | 1 | 2019 | 1033 | 0.500 |
Why?
|
| Membrane Proteins | 3 | 2021 | 7873 | 0.500 |
Why?
|
| Analgesics | 1 | 2021 | 1037 | 0.480 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2020 | 814 | 0.480 |
Why?
|
| Telomere | 1 | 2020 | 909 | 0.480 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1835 | 0.450 |
Why?
|
| Turner Syndrome | 1 | 2014 | 130 | 0.440 |
Why?
|
| Cystadenocarcinoma, Serous | 3 | 2022 | 450 | 0.430 |
Why?
|
| Laparoscopy | 3 | 2022 | 2121 | 0.430 |
Why?
|
| Menstruation | 1 | 2014 | 299 | 0.420 |
Why?
|
| Anemia, Neonatal | 1 | 2011 | 18 | 0.400 |
Why?
|
| Aspirin | 1 | 2023 | 3278 | 0.390 |
Why?
|
| Case-Control Studies | 9 | 2023 | 21719 | 0.380 |
Why?
|
| Blood Group Antigens | 1 | 2011 | 179 | 0.350 |
Why?
|
| Parity | 2 | 2021 | 929 | 0.310 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3584 | 0.300 |
Why?
|
| Isoantibodies | 1 | 2011 | 680 | 0.290 |
Why?
|
| Female | 34 | 2023 | 379592 | 0.280 |
Why?
|
| Pain | 2 | 2022 | 4961 | 0.270 |
Why?
|
| Proteomics | 3 | 2023 | 3618 | 0.260 |
Why?
|
| Exercise | 1 | 2021 | 5611 | 0.240 |
Why?
|
| Endometrial Neoplasms | 1 | 2014 | 1351 | 0.240 |
Why?
|
| Diet | 1 | 2022 | 7923 | 0.240 |
Why?
|
| Nutrition Surveys | 2 | 2021 | 1656 | 0.230 |
Why?
|
| Adult | 18 | 2022 | 213712 | 0.210 |
Why?
|
| Young Adult | 10 | 2022 | 56350 | 0.210 |
Why?
|
| New England | 2 | 2021 | 1021 | 0.200 |
Why?
|
| Carcinoma | 2 | 2023 | 2374 | 0.200 |
Why?
|
| Humans | 35 | 2023 | 742088 | 0.190 |
Why?
|
| Transcytosis | 1 | 2021 | 44 | 0.190 |
Why?
|
| Intrauterine Devices | 1 | 2021 | 122 | 0.170 |
Why?
|
| Contraceptives, Oral | 1 | 2021 | 563 | 0.160 |
Why?
|
| Adolescent | 7 | 2022 | 85649 | 0.160 |
Why?
|
| Pelvis | 1 | 2022 | 730 | 0.150 |
Why?
|
| Tumor Microenvironment | 4 | 2023 | 3564 | 0.150 |
Why?
|
| Specimen Handling | 1 | 2022 | 692 | 0.150 |
Why?
|
| 5-Methylcytosine | 1 | 2017 | 153 | 0.150 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 707 | 0.150 |
Why?
|
| Immunoglobulin A | 1 | 2021 | 992 | 0.150 |
Why?
|
| Epithelium, Corneal | 1 | 2019 | 241 | 0.150 |
Why?
|
| Abdominal Pain | 1 | 2023 | 1059 | 0.140 |
Why?
|
| Risk Factors | 7 | 2022 | 72145 | 0.140 |
Why?
|
| Prospective Studies | 7 | 2023 | 53187 | 0.140 |
Why?
|
| Nandrolone | 1 | 2016 | 17 | 0.140 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 6347 | 0.140 |
Why?
|
| Estrogens | 1 | 2023 | 1562 | 0.140 |
Why?
|
| Pregnancy | 6 | 2021 | 29087 | 0.140 |
Why?
|
| Japan | 3 | 2021 | 1360 | 0.130 |
Why?
|
| Hormone Antagonists | 1 | 2016 | 107 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2021 | 1533 | 0.130 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 687 | 0.120 |
Why?
|
| Ovarian Diseases | 1 | 2016 | 139 | 0.120 |
Why?
|
| Neoplasms | 2 | 2022 | 21596 | 0.120 |
Why?
|
| Middle Aged | 10 | 2021 | 213127 | 0.120 |
Why?
|
| Causality | 1 | 2021 | 1265 | 0.120 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2021 | 1320 | 0.120 |
Why?
|
| Abortion, Spontaneous | 1 | 2019 | 542 | 0.120 |
Why?
|
| Salpingectomy | 1 | 2014 | 52 | 0.120 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2021 | 1820 | 0.110 |
Why?
|
| Follow-Up Studies | 5 | 2022 | 39004 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2021 | 2739 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 1983 | 0.110 |
Why?
|
| Aged | 10 | 2023 | 162944 | 0.110 |
Why?
|
| Staphylococcal Infections | 1 | 2021 | 1398 | 0.100 |
Why?
|
| Pain, Postoperative | 1 | 2022 | 1638 | 0.100 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 24913 | 0.100 |
Why?
|
| Breast Feeding | 1 | 2020 | 1339 | 0.100 |
Why?
|
| Ovariectomy | 1 | 2014 | 660 | 0.100 |
Why?
|
| Nurses | 1 | 2021 | 2459 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2276 | 0.100 |
Why?
|
| Fetal Monitoring | 1 | 2011 | 70 | 0.100 |
Why?
|
| Mosaicism | 1 | 2014 | 440 | 0.100 |
Why?
|
| Lipids | 1 | 2022 | 3302 | 0.090 |
Why?
|
| Health Surveys | 1 | 2021 | 4030 | 0.090 |
Why?
|
| United States | 4 | 2022 | 69693 | 0.090 |
Why?
|
| Gene Expression | 1 | 2023 | 7790 | 0.090 |
Why?
|
| Labor, Induced | 1 | 2011 | 146 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 2026 | 0.090 |
Why?
|
| Middle Cerebral Artery | 1 | 2011 | 264 | 0.090 |
Why?
|
| Prevalence | 2 | 2023 | 15194 | 0.090 |
Why?
|
| Boston | 1 | 2022 | 9305 | 0.090 |
Why?
|
| Women's Health | 1 | 2019 | 2034 | 0.090 |
Why?
|
| Epidemiologic Studies | 2 | 2023 | 676 | 0.080 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2011 | 571 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2023 | 14720 | 0.080 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2011 | 732 | 0.080 |
Why?
|
| Hysterectomy | 1 | 2014 | 927 | 0.080 |
Why?
|
| Lymph Node Excision | 1 | 2014 | 1248 | 0.080 |
Why?
|
| Mass Screening | 1 | 2023 | 5238 | 0.080 |
Why?
|
| Age Factors | 2 | 2021 | 18355 | 0.070 |
Why?
|
| Blood Flow Velocity | 1 | 2011 | 1423 | 0.070 |
Why?
|
| Stem Cells | 1 | 2019 | 3563 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 12344 | 0.070 |
Why?
|
| Registries | 1 | 2021 | 8077 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 2861 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2022 | 40450 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 3639 | 0.060 |
Why?
|
| Prognosis | 3 | 2021 | 29010 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2011 | 1694 | 0.060 |
Why?
|
| Inflammation | 1 | 2022 | 10578 | 0.050 |
Why?
|
| Cyclin E | 1 | 2022 | 172 | 0.050 |
Why?
|
| Algorithms | 1 | 2020 | 13853 | 0.040 |
Why?
|
| Ki-67 Antigen | 1 | 2021 | 644 | 0.040 |
Why?
|
| Premature Birth | 1 | 2011 | 1713 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2021 | 1094 | 0.040 |
Why?
|
| Oncogene Proteins | 1 | 2022 | 749 | 0.040 |
Why?
|
| Limbus Corneae | 1 | 2019 | 142 | 0.040 |
Why?
|
| Receptors, Fc | 1 | 2021 | 540 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2022 | 13029 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2021 | 25575 | 0.040 |
Why?
|
| Child | 2 | 2023 | 77478 | 0.030 |
Why?
|
| Dioxygenases | 1 | 2017 | 316 | 0.030 |
Why?
|
| Recurrence | 2 | 2017 | 8333 | 0.030 |
Why?
|
| Cell Separation | 1 | 2019 | 1749 | 0.030 |
Why?
|
| Disease Progression | 2 | 2021 | 13256 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2019 | 2205 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2021 | 4024 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3557 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 57683 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2023 | 11363 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 2795 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2021 | 3766 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5872 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2019 | 3678 | 0.020 |
Why?
|
| Survival Rate | 1 | 2021 | 12773 | 0.020 |
Why?
|
| Risk | 1 | 2019 | 9679 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15994 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2016 | 3418 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10472 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 8621 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 6891 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 4553 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2017 | 10248 | 0.020 |
Why?
|
| Incidence | 1 | 2022 | 20928 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 19862 | 0.010 |
Why?
|
| Depression | 1 | 2023 | 7733 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2017 | 4282 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2022 | 12164 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 8425 | 0.010 |
Why?
|
| Quality of Life | 1 | 2022 | 12730 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9639 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18006 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2016 | 77098 | 0.010 |
Why?
|
| Male | 2 | 2022 | 349538 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 81045 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 168561 | 0.000 |
Why?
|
Concepts
(157)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_